ProKidney Corp. Rings the Opening Bell

ABOUT THIS EVENT

ProKidney Corp. (Nasdaq: PROK), a leading clinical-stage cellular therapeutics company focused on chronic kidney disease (“CKD”), visits the Nasdaq MarketSite in Times Square to commemorate the closing of its business combination with Social Capital Suvretta Holdings Corp. III.

In honor of the occasion, Pablo Legorreta, Chairman, and Tim Bertram, Founder and CEO of ProKidney, rings the Opening Bell.

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore